CA1236736A - Dispositif pour administrer des medicaments aux malades - Google Patents

Info

Publication number

CA1236736A

CA1236736A CA000509193A CA509193A CA1236736A CA 1236736 A CA1236736 A CA 1236736A CA 000509193 A CA000509193 A CA 000509193A CA 509193 A CA509193 A CA 509193A CA 1236736 A CA1236736 A CA 1236736A

Authority

CA

Canada

Prior art keywords

pack

medicament

blister

sheet

container

Prior art date

1982-10-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 239000003814 drug Substances 0.000 title claims abstract description 43
• 239000007787 solid Substances 0.000 claims abstract description 4
• 239000000843 powder Substances 0.000 claims description 16
• 239000011888 foil Substances 0.000 claims description 5
• KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 claims description 3
• NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 claims description 3
• 229950000210 beclometasone dipropionate Drugs 0.000 claims description 3
• 229960000265 cromoglicic acid Drugs 0.000 claims description 3
• IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
• 239000002648 laminated material Substances 0.000 claims description 3
• 239000002245 particle Substances 0.000 claims description 3
• 229960002052 salbutamol Drugs 0.000 claims description 3
• 239000008101 lactose Substances 0.000 claims description 2
• 239000007788 liquid Substances 0.000 abstract description 2
• 239000002775 capsule Substances 0.000 description 12
• 208000002352 blister Diseases 0.000 description 3
• 108010010803 Gelatin Proteins 0.000 description 2
• 230000000994 depressogenic effect Effects 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 206010006429 Bronchial conditions Diseases 0.000 description 1
• 101150005343 INHA gene Proteins 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 238000000034 method Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 238000012856 packing Methods 0.000 description 1
• ACXGJHCPFCFILV-UHFFFAOYSA-M sodium;2-(4-chloro-2-methylphenoxy)acetate;3,6-dichloro-2-methoxybenzoic acid Chemical compound [Na+].COC1=C(Cl)C=CC(Cl)=C1C(O)=O.CC1=CC(Cl)=CC=C1OCC([O-])=O ACXGJHCPFCFILV-UHFFFAOYSA-M 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1